Geistlich Pharma AG

Geistlich Pharma AG is a family-owned Swiss MedTech company founded in 1851 and headquartered in Wolhusen, Switzerland. Recognized as the global leader in regenerative biomaterials, Geistlich specializes in bone and soft tissue regeneration solutions for dentistry, orthopedics, and infectiology. The company's flagship product portfolio includes Geistlich Bio-Oss® (bone replacement material for jawbone reconstruction), Bio-Gide® membranes (guided tissue regeneration), Chondro-Gide® (cartilage regeneration), and orthopedic solutions including AMIC technology for cartilage repair. Geistlich also manufactures pharmaceuticals and medical devices such as Taurolin® and TauroSept® for infection control, and Derma-Gide® for advanced wound care. With a strong commitment to evidence-based innovation and quality in bone and collagen processing, Geistlich maintains a global distribution network serving dental professionals, orthopedic surgeons, and medical specialists across 150+ countries.